Acadia pharmaceuticals to participate in the ubs virtual cns day

San diego--(business wire)--acadia pharmaceuticals inc. (nasdaq: acad) today announced that it will participate in the ubs virtual cns day on monday, march 18, 2024 at 2:00 p.m. eastern time. the conference will be held virtually. a live webcast of acadia's presentation will be accessible on the company's website, acadia.com, under the investors section and an archived recording will be available on the website for approximately one month following the presentation. about acadia pharmaceuticals.
ACAD Ratings Summary
ACAD Quant Ranking